This paper is marked retracted in the scholarly record (OpenAlex). Interpret its findings with caution.
[Retracted] RNAi‑mediated EZH2 depletion decreases MDR1 expression and sensitizes multidrug‑resistant hepatocellular carcinoma cells to chemotherapy
Bo Tang, Yi Zhang, Rui Liang, Zhenming Gao, Deguang Sun, Liming Wang
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsEpigenetics and DNA Methylation · RNA modifications and cancer · Cancer-related molecular mechanisms research
Oncol Rep 29: 1037–1042, 2013; DOI: 10.3892/or.2013.2222
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that the control western blotting data featured in Fig. 2C on p. 1039 and the cell cycle distribution images shown in Fig. 6A on p. 1041 were strikingly similar to data that had appeared in a pair of other articles written by different authors at different research institutes, one of which had already been submitted for publication when this article was received at Oncology Reports, the other of which was received some time afterwards, but which has subsequently been retracted. Owing to the fact that the abovementioned data had already been submitted for publication prior to its submission to Oncology Reports, the Editor has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.